Aviva Holdings’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-3,135,966
Closed -$137M 4
2023
Q3
$137M Hold
3,135,966
87.83% 1
2023
Q2
$113M Hold
3,135,966
82.86% 1
2023
Q1
$117M Hold
3,135,966
81.37% 1
2022
Q4
$142M Hold
3,135,966
81.47% 1
2022
Q3
$219M Hold
3,135,966
79.2% 1
2022
Q2
$211M Hold
3,135,966
75.77% 1
2022
Q1
$258M Hold
3,135,966
68.01% 1
2021
Q4
$460M Hold
3,135,966
74.85% 1
2021
Q3
$555M Hold
3,135,966
78.28% 1
2021
Q2
$507M Hold
3,135,966
69.99% 1
2021
Q1
$537M Hold
3,135,966
71.4% 1
2020
Q4
$689M Hold
3,135,966
67.42% 1
2020
Q3
$521M Hold
3,135,966
67.85% 1
2020
Q2
$358M Hold
3,135,966
55.71% 1
2020
Q1
$241M Buy
3,135,966
+275,000
+10% +$24.7M 54.92% 1
2019
Q4
$369M Sell
2,860,966
-275,000
-9% -$26.5M 60.11% 1
2019
Q3
$244M Hold
3,135,966
57.48% 1
2019
Q2
$323M Hold
3,135,966
67.56% 1
2019
Q1
$230M Hold
3,135,966
50.43% 1
2018
Q4
$133M Hold
3,135,966
41.94% 1
2018
Q3
$148M Hold
3,135,966
39.41% 1
2018
Q2
$155M Hold
3,135,966
25.1% 2
2018
Q1
$96.3M Hold
3,135,966
39.06% 2
2017
Q4
$57.2M Buy
3,135,966
+255,264
+9% +$3.96M 33.52% 2
2017
Q3
$33.7M Sell
2,880,702
-1,000
-0% -$5.79K 17.52% 2
2017
Q2
$10.5M Hold
2,881,702
6.63% 3
2017
Q1
$15M Buy
2,881,702
+889,617
+45% +$4.88M 6.99% 2
2016
Q4
$9.46M Hold
1,992,085
9.13% 2
2016
Q3
$13.2M Hold
1,992,085
100% 1
2016
Q2
$10.9M Buy
1,992,085
+446,084
+29% +$7.11M 8.55% 2
2016
Q1
$33.3M Buy
1,546,001
+1,023,501
+196% +$22.9M 23.32% 3
2015
Q4
$16.5M Buy
+522,500
New +$18.5M 18.1% 3

Other funds holding MRTX